Pierre Fabre's PLA.I.GROUND Generative AI Platform Reaches 50% Daily Employee Adoption
French pharmaceutical and cosmetics group Pierre Fabre launched PLA.I.GROUND in 2023, an internal, secure, multi-model generative AI assistant built on Microsoft Azure and Azure OpenAI Service and available to all employees worldwide. More than 50% of office-based employees use it daily to summarize documents, generate content and accelerate code development. Pierre Fabre has also rolled out PLA.I.Expert and developed a proprietary framework for chatbots and conversational agents, and Oncoguide, an emblematic use case with an AI conversational agent, is used by 3,400 retail pharmacists in France.
Overview
French pharmaceutical and cosmetics group Pierre Fabre launched PLA.I.GROUND in 2023, an internal, secure, multi-model generative AI assistant built on Microsoft Azure and Azure OpenAI Service and available to all employees worldwide. More than 50% of office-based employees use it daily to summarize documents, generate content and accelerate code development. Pierre Fabre has also rolled out PLA.I.Expert and developed a proprietary framework for chatbots and conversational agents, and Oncoguide, an emblematic use case with an AI conversational agent, is used by 3,400 retail pharmacists in France.
This entry has 13 published fields tied to exact passages in an immutable source capture.
Inspect the highlighted sourceThe challenge
In a global pharmaceutical and cosmetics market defined by intense competition, where Pierre Fabre competes with companies 10 to 15 times its size, the company needed to accelerate time-to-market, transform processes, and improve efficiency.
The solution
In 2023 Pierre Fabre launched PLA.I.GROUND, an internal generative AI assistant built on Microsoft Azure and Azure OpenAI Service. It is a secure, contextualized, multi-model enterprise platform that leverages multiple LLMs orchestrated through Microsoft Azure to ensure security, scalability and compliance, tailored to business use cases from writing and analysis to text, image and code generation. The company has since rolled out PLA.I.Expert, a specialized generative AI trained on domain-specific knowledge bases, and developed a proprietary framework to create chatbots and conversational agents leveraging the foundations of PLA.I.GROUND.
Reported business value
More than 50% of Pierre Fabre's office-based employees use PLA.I.GROUND on a daily basis, and the company's Chief Data & AI Officer says teams spend less time on low-value tasks, freeing up time for innovation. Oncoguide, which integrates an AI-powered conversational agent to provide scientifically validated information at the pharmacy counter, is already used by 3,400 retail pharmacists in France.
Sources
Open any source and check the claim yourself — that is the point of the register.
This record was researched and written with AI assistance, and its claims were checked against the sources above. (EU AI Act art. 50 transparency notice.)
Other healthcare entries in the register.
Less paperwork, more time for people: Azure OpenAI at Landsberg Hospital
Klinikum Landsberg am Lech, a German acute-care hospital, deployed an AI language solution built on Azure OpenAI with partner Pexon Consulting that transcribes doctor-patient consultations in real time via tablet, recognizes medical terms, structures the content, and transfers it directly into the hospital information system.
Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research
Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.
Novo Nordisk· DenmarkAzure OpenAI Service · Azure Cosmos DB · Azure Kubernetes Service +2BAYADA Builds a Unified, AI-Ready Platform for Compassionate Care
BAYADA Home Health Care is consolidating three separate legacy data platforms (multiple practice management systems, an on-prem ODS, and Snowflake) and 65+ enterprise data sources into a single Databricks Lakehouse under its Data Modernization program, using medallion tiers, Lakeflow Jobs, Asset Bundles, and Unity Catalog governance. As part of the migration, BAYADA uses an LLM-powered code converter and Databricks Assistant to automate SQL and stored-procedure translation, and applies a machine learning-based data mastering accelerator to create golden Client, Payor, Candidate, and Referrer records. BAYADA reports roughly 30% better workload performance and cost efficiency versus its prior Snowflake environment, and is laying a governed foundation for AI agents supporting payroll validation, compliance monitoring, and operational insights, separately from its roadmap for AI-assisted chart review and risk prediction.
BAYADA Home Health CareDatabricks SQL · Lakeflow Jobs · Unity Catalog +1
Heidi Health fine-tunes NVIDIA Parakeet/Nemotron ASR, cutting clinical transcription latency 75% and costs 64%
Heidi Health, which processes 2.4 million clinical consultations weekly across 110 languages, fine-tuned the open NVIDIA Parakeet V2 speech recognition model on 1,500 hours of curated clinical audio using the NVIDIA NeMo framework and 8x H100 GPUs, replacing its closed-source vendor ASR. The in-house Nemotron-based ASR stack cut end-to-end transcription latency from about 3.0 seconds to 0.7 seconds (75%+ improvement), reduced word error rate from 13% to 9.4%, and cut operating costs by 64% by eliminating per-minute API pricing, while giving Heidi full ownership of model weights for data sovereignty.
Was this helpful?
Your feedback helps us improve our use case database